Literature DB >> 17270598

Targeted molecular therapy for renal cell carcinoma.

Brian R Lane1, Brian I Rini, Andrew C Novick, Steven C Campbell.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17270598     DOI： 10.1016/j.urology.2006.09.028

Source DB:  PubMed          Journal:  Urology        ISSN： 0090-4295            Impact factor:   2.649


× No keyword cloud information.
  17 in total

1.  Health-related quality of life in Japanese patients with metastatic renal cell carcinoma treated with sunitinib.

Authors:  Hideaki Miyake; Ken-Ichi Harada; Yuji Kusuda; Masato Fujisawa
Journal:  Int J Clin Oncol       Date:  2011-12-27       Impact factor: 3.402

2.  Third-line sunitinib following sequential use of cytokine therapy and sorafenib in Japanese patients with metastatic renal cell carcinoma.

Authors:  Hideaki Miyake; Yuji Kusuda; Ken-ichi Harada; Iori Sakai; Masato Fujisawa
Journal:  Int J Clin Oncol       Date:  2011-11-18       Impact factor: 3.402

3.  The role of percutaneous renal biopsy in the management of small renal masses.

Authors:  Rou Wang; Amy Y Li; David P Wood
Journal:  Curr Urol Rep       Date:  2011-02       Impact factor: 3.092

Review 4.  The von Hippel-Lindau gene: turning discovery into therapy.

Authors:  Peter E Clark; Michael S Cookson
Journal:  Cancer       Date:  2008-10-01       Impact factor: 6.860

5.  Metastatic renal cell carcinoma presenting as a cardiac tumour.

Authors:  Nisha Krishnakant Raiker; Erin Jensen; Bernadette Wodzinski; Kameswari Maganti
Journal:  BMJ Case Rep       Date:  2018-12-22

6.  Pulmonary metastasectomy in patients with renal cell carcinoma: a single-institution experience.

Authors:  Atsunari Kawashima; Masashi Nakayama; Daizo Oka; Mototaka Sato; Koji Hatano; Masatoshi Mukai; Akira Nagahara; Yasutomo Nakai; Hitoshi Takayama; Masayoshi Inoue; Hiroyuki Shiono; Kazuo Nishimura; Meinoshin Okumura; Norio Nonomura
Journal:  Int J Clin Oncol       Date:  2011-05-10       Impact factor: 3.402

Review 7.  p53 and MDM2 in renal cell carcinoma: biomarkers for disease progression and future therapeutic targets?

Authors:  Aidan P Noon; Nikolina Vlatković; Radosław Polański; Maria Maguire; Howida Shawki; Keith Parsons; Mark T Boyd
Journal:  Cancer       Date:  2010-02-15       Impact factor: 6.860

8.  Rationale for targeted therapies and potential role of pazopanib in advanced renal cell carcinoma.

Authors:  Peter E Clark
Journal:  Biologics       Date:  2010-08-09

Review 9.  The role of VHL in clear-cell renal cell carcinoma and its relation to targeted therapy.

Authors:  Peter E Clark
Journal:  Kidney Int       Date:  2009-08-05       Impact factor: 10.612

10.  Aqueous Extract of Paeonia suffruticosa Inhibits Migration and Metastasis of Renal Cell Carcinoma Cells via Suppressing VEGFR-3 Pathway.

Authors:  Shih-Chin Wang; Sai-Wen Tang; Sio-Hong Lam; Chung-Chieh Wang; Yu-Huei Liu; Hsuan-Yuan Lin; Shoei-Sheng Lee; Jung-Yaw Lin
Journal:  Evid Based Complement Alternat Med       Date:  2012-02-08       Impact factor: 2.629
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.